DoH rejects calls for independent overhaul of NICE

Proposals for an independent inquiry into NICE's methods, and plans to include patient views in assessments, have been rejected by the government.

A research review by Sir David Cooksey, a venture capitalist who has held a variety of government advisory posts, recommended an independent review into how NICE calculates medicines’ cost-effectiveness.

The current evaluation system needs to be complemented by input from clinicians, patients and researchers, he said.

The government rejected the advice, however, pointing to recent and planned changes to NICE and its guidelines.

‘We do not believe an independent inquiry as proposed by Sir David is the right way of addressing the specific issues his report raises,’ the DoH said.

‘NICE has open and transparent processes,’ it added. ‘It consults periodically on both its technology appraisal methods and its appraisal processes, and is currently concluding the latest scheduled review of its appraisal process manual.’

See this week’s GP, dated 15 May for the full story.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us: